bpc-157 safety risks What is BPC-157? Should the FDA ease restrictions

Coverage at NY Times, front page today and my input to that piece To view or add a comment, sign in Pseudoscience So heres the whole story on why the FDA is endorsing peptides where there is a lack of solid scientific evidence that they have any effect eg on inflammation, weight loss, longeivity Essentially they added 6 people to the decision making committee who had a specific interests in supporting the sale of these peptides

What Stronger Future Evidence Would Need to Show Stronger BPC-157 evidence would require more independent replication across laboratories, clearer pathway-dissection experiments, better separation of migration and proliferation endpoints, standardized peptide-quality documentation, and more transparent reporting of model conditions

The presence of B12 deficiency itself may indicate an underlying digestive disorder that requires specific investigation and management

Intramuscular B12 injections are ideal for those with pernicious anemia or severe malabsorption due to GI disease or surgery

B12 injections go straight into your muscle and bloodstream, so your body takes up most of the dose, while oral B12 has to pass through your digestive system first, where only a small fraction of a tablet gets absorbed

Potential Limitations and Cautions While AOD 9604s prospects seem promising, its pivotal to acknowledge potential limitations: Data on long-term safety is still in the nascent stages